T he U.S. Food and Drug Administration (FDA) has granted approval for Cleveland Diagnostics' IsoPSA  in vitro diagnostic (IVD) kit. This decision marks a significant advancement in prostate cancer risk assessment, providing physicians with an important new tool. Approved via the premarket approval (PMA) process, the blood-based test is intended to assist physicians in deciding on the necessity of a prostate biopsy for men aged 50 years and older who have elevated prostate-specific antigen (PSA) levels. Prostate cancer is the second most common cancer in American men. While over one million men undergo prostate biopsies each year in the U.S., studies show that as many as 75% of those follow-up tests are negative for high-grade disease . This diagnostic gap exposes millions to invasive, costly procedures that carry physical risks and emotional stress. IsoPSA aims to close this gap by providing a more accurate risk assessment. The test leverages Cleveland Diagnostics’ IsoClear platform to analyze protein biomarkers at a structural level in blood samples. Unlike traditional PSA screening, IsoPSA evaluates cancer-specific structural variants of the PSA protein to identify the origin of the proteins, helping to assess whether a patient may have high-grade cancer. Dr. Eric Klein, Emeritus chair of the Cleveland Clinic Glickman Urological & Kidney Institute, stated that the FDA approval underscores the clinical utility of IsoPSA in distinguishing benign elevations of PSA from those due to high grade cancer . Urologists recognize the critical need for early and accurate risk assessment, noting that current PSA testing limitations often lead to unnecessary procedures and anxiety. The FDA's decision was based on clinical evidence from a large-scale, prospective study conducted at 14 sites across the U.S., supported by analytical validation trials. The company has been offering IsoPSA as a laboratory-developed test (LDT) since 2020. Furthermore, IsoPSA is already included in leading clinical practice guidelines, such as the National Comprehensive Cancer Network (NCCN) Prostate Cancer Early Detection Guideline (2025) and the Early Detection of Prostate Cancer: American Urology Association/Society of Urologic Oncology Guideline (2023). Arnon Chait, CEO and president of Cleveland Diagnostics, emphasized that the approval marks a "significant milestone" in the company's mission to help physicians and patients detect cancer early when it is most treatable and survivable. The company remains focused on expanding access to the test nationwide. 🔖 Sources FDA Approves IsoPSA® -- Cleveland Diagnostics’ Novel Blood-Based Prostate Cancer Test Cleveland Diagnostics’ IsoPSA secures FDA approval for prostate cancer FDA approves next-gen prostate cancer PSA test from Cleveland Diagnostics Keywords: IsoPSA Avoids Unnecessary Prostate Biopsies  IsoPSA Avoids Unnecessary Prostate Biopsies

M edtronic has successfully secured initial stateside clearance from the U.S. Food and Drug Administration (FDA) for its Hugo robotic-assisted surgery (RAS) platform, setting the stage for increased competition in the lucrative U.S. robotic surgery market. The clearance, announced December 3, 2025, specifically covers soft-tissue, minimally invasive multiport procedures for urologic surgeries. This initial green light includes complex procedures such as the removal of the prostate, kidneys, and bladder (prostatectomy, nephrectomy, and cystectomy). Medtronic estimates these procedures account for approximately 230,000 surgeries performed annually in the U.S.. The company views this milestone as a means to expand robotic programs in hospitals and increase patient access to minimally invasive care across the country. The introduction of Hugo addresses the challenge of capacity and access in the U.S., which leads the world in robotic surgery adoption. Rajit Kamal, Medtronic’s vice president of robotic surgical technologies, stated that the clearance provides choice for hospitals looking to expand their robotic capabilities. The Hugo system is differentiated by its modular design , featuring multiple robotic arms placed on individual wheeled carts, making the system portable and deployable across any healthcare setting. Furthermore, the system integrates seamlessly with the Touch Surgery digital ecosystem , which supports pre-operative planning, remote tele-proctoring, video education programs, and artificial intelligence-powered insights for clinicians. Medtronic intends to launch the Hugo RAS system purposefully, building strong foundations with leading hospitals through a commitment to differentiated partnership and world-class training. The company also plans to expand the robot’s scope in the U.S. beyond urology, with indications for general and gynecologic procedures expected to follow. Already active overseas, Hugo has logged tens of thousands of procedures across more than 30 countries and five continents since its 2021 debut. Hugo enters a competitive arena, vying for market share with major systems like Intuitive's da Vinci 5, as well as newer FDA-cleared international systems such as CMR Surgical’s Versius and Distalmotion’s Dexter. The addition of the Hugo RAS system, coupled with Medtronic's existing surgical offerings, is expected to create a connected and integrated operating room for the future. 🔖 Sources Medtronic announces FDA clearance of Hugo™ robotic-assisted surgery system for urologic surgical procedures Medtronic's Hugo surgical robot secures US clearance Keywords: Medtronic Hugo RAS system FDA clearance   Medtronic Hugo RAS system FDA clearance

I n a significant resolution concerning government healthcare funds, national retail pharmacy chain CVS  has agreed to pay $37.76 million  to settle allegations of violating the federal False Claims Act . The settlement resolves a healthcare fraud  lawsuit covering alleged practices that took place over a decade, between 2010 and 2020. The core issue centered on the dispensing of insulin pens  to patients enrolled in government programs, such as Medicare, Medicaid, TRICARE, and the Federal Employees Health Benefits Program (FEHBP). Authorities alleged that CVS pharmacies repeatedly submitted reimbursement claims for premature refills, dispensed more insulin than patients required, and underreported the days-of-supply for the medicine. This conduct allegedly limited the system’s ability to prevent these premature refills. U.S. Attorney Jay Clayton noted that these practices led to higher-than-necessary payments by insurers for insulin, affecting funds designated for the healthcare of individuals on government programs. Specifically, CVS allegedly instructed pharmacy staff to report the maximum days-of-supply when dispensing full insulin pen cartons, allowing prescriptions to be filled as quickly as possible and ensuring reimbursement claims were approved. CVS also acknowledged that its auto-refill program sometimes triggered premature refills based on inaccurate data. As part of the resolution, CVS acknowledged responsibility for certain patterns of conduct and admitted that some of its pharmacies failed to follow proper billing procedures, particularly when dispensing full insulin pen cartons. The financial settlement dictates that $24,446,240  will be paid to the United States (the federal government), with the remaining funds distributed among various states. Government officials emphasized the seriousness of protecting federal healthcare funds. Naomi D. Gruchacz, Special Agent in Charge of the HHS-OIG, highlighted the importance of investigating allegations of improper billing to protect the federal healthcare system and the enrollees dependent on its programs. Derek M. Holt, Special Agent in Charge of the OPM-OIG, added that submitting claims for insulin refills beyond medical necessity directly impacts federal employee benefits and increases costs within the system. The investigation leading to the settlement involved collaboration among several federal bodies, including the Department of Health and Human Services, the Department of Defense, and the Office of Personnel Management. The resolution also settles several whistleblower cases, the first of which was brought in 2018 by CVS pharmacist Adam Rahimi. Whistleblowers are set to receive 19.5% of the total settlement amount. In response to the settlement, CVS stated that billing for insulin pens "has long been a challenge for pharmacies," citing factors like variable dosing, packaging, labeling changes, and varying payor supply limits. The company expressed satisfaction in putting the issue behind them, noting that the evolution of pharmacy benefit managers (PBMs) and technological enhancements are helping to alleviate some of these challenges. The case serves as a crucial reminder of the importance of adhering to stringent healthcare regulations. This case underscores that maintaining the integrity of federal healthcare programs—often seen as a complex web of rules and procedures—requires strict adherence to billing guidelines, acting as a mandatory lock on the vault protecting taxpayer dollars designated for patient care. 🔖 Sources CVS settles insulin dispensing case for $38M CVS Settles for $37.76 Million in Healthcare Fraud Lawsuit Over Insulin Pen Over-Dispensing CVS to pay $37.8 million to settle claims over insulin pens CVS Agrees to Pay $38 Million to Resolve Insulin Fraud Claims Keywords: CVS Settlement CVS Settlement

T he landscape of healthcare management across the United States is seeing significant shifts, particularly within HCA Healthcare, the Nashville, Tenn.-based for-profit health system. Recent reports highlight an extensive HCA Healthcare Leadership  overhaul, recording more than two dozen (25) Hospital CEO Moves  this year at facilities operated by HCA. This widespread restructuring, detailed in a list compiled on January 9 and updated through December 3, demonstrates a concerted effort to refresh leadership nationwide. Since December 3, HCA Healthcare has appointed 25 new chief executives across its hospitals, bringing diverse expertise into vital roles. These changes are geographically extensive, spanning hospitals in Florida, Tennessee, Virginia, Georgia, New Hampshire, Utah, Texas, Missouri, South Carolina, and Alaska. Among the key appointments are Alexis Mussi , who was named CEO of MountainView Hospital in Las Vegas, having previously served as CEO of Southern Hills Hospital and Medical Center. Other notable changes include Patrick Rafferty  stepping in as CEO of Centerpoint Medical Center in Independence, Mo., and Mark Roberts  taking the helm at Alaska Regional Hospital in Anchorage. On the East Coast, Sean Patterson  was appointed CEO of Portsmouth (N.H.) Regional Hospital, and Nanette Logan, DNP , became CEO of Dominion Hospital in Falls Church, Va.. Further illustrating the system-wide scope, appointments also included Colin O’Sullivan  at HCA Healthcare Colleton Medical Center in South Carolina and Dale Neely  at HCA Florida Capital Hospital in Tallahassee. A critical takeaway from this large-scale turnover is the strong presence of Clinical Expertise  among the new leaders. Several of the newly appointed CEOs hold nursing degrees (RNs, BSNs, DNPs), underscoring the system’s drive to integrate hands-on healthcare understanding with executive decision-making. For instance, new appointments included Nicole Tucker, RN  (CEO of LewisGale Hospital Alleghany in Low Moor, Va.), Jerry Gonzalez, BSN, RN  (CEO of Ogden Regional Medical Center in Utah), and Elias Armendariz, MSN, RN  (CEO of HCA Houston Healthcare Pearland in Texas). Additionally, Kelsie Green, BSN, RN , was appointed to a dual role as CEO and chief nursing officer of Cache Valley Hospital in Logan, Utah. This incorporation of clinical experience is expected to help leaders better understand healthcare challenges and improve patient care. The overall goal of these shifts is to bring fresh ideas and energy to enhance patient care and operational efficiency across the HCA system. While the hospital CEO Moves  command headlines, other significant HCA Healthcare Leadership  changes are also in motion. HCA's executive restructuring included the naming of anesthesiologist Jack Atwater, MD , as chief medical officer of HCA Florida Capital Hospital in Tallahassee. Simultaneously, former HCA market CFO Jacob Wiesmann  moved outside the system to become divisional CFO at Beth Israel Lahey Health. Furthermore, the leadership of HCA’s Surgery Ventures division—which operates approximately 150 surgery centers in 16 states—remains robust. Key figures in this division include President Greg Beasley , a 30-year HCA veteran, Chief Operating Officer Shaun Cartwright  (named July 2025), and Chief Financial Officer David McKnight . The division also highlights clinical leadership with CMO Peter Harkness, MD , a board-certified anesthesiologist with 21 years of private practice experience, and Chief Nurse Executive Sharon Ikeler, DNP, RN, NEA-BC , who has 28 years of nursing experience. These executive appointments signal that HCA Healthcare is strategically deploying experienced and clinically knowledgeable Leadership  to face new challenges, meet community needs more effectively, and innovate healthcare quality across its expansive system. 🔖 Sources 25 CEO moves at HCA 25 CEO moves shake up leadership at HCA Healthcare hospitals across the U.S. HCA’s leadership restructuring: 4 moves to know Surgery Ventures leadership Keywords: HCA Healthcare Leadership HCA Healthcare Leadership

Image credit: Deadline / Grey's Anatomy . Fair use. T he television landscape is rapidly evolving, defined by the unstoppable rise of on-demand consumption and the enduring resilience of established cultural phenomena. Streaming has consistently shattered viewing records , fundamentally reshaping how audiences engage with content, yet linear TV still plays a vital role in amplifying the reach of marquee shows. Nielsen’s monthly reports underscore this dramatic shift, confirming that the audience migration away from traditional broadcast and cable formats continues unabated. Amidst this intense competition for viewer minutes, one long-running medical drama, Grey's Anatomy , stands out as a powerful example of how longevity, consistent quality, and strategic multi-platform distribution translate into massive viewership figures. Analyzing the latest Nielsen Streaming Data  reveals the intricate mechanics behind the show's sustained Grey's Anatomy Streaming Success  and highlights the tremendous value of Acquired Content Power  in the current media ecosystem. Content ⁉️ 1️⃣ The New Hierarchy of Viewing: Streaming’s Record Ascent 2️⃣ Grey's Anatomy: A Case Study in Acquired Content Power 3️⃣ The Battle for the Top Spot on Nielsen Streaming Data 4️⃣ Digital Engagement and Cultural Phenomenon 🔖 Key Takeaways The New Hierarchy of Viewing: Streaming’s Record Ascent T he latest viewing metrics clearly indicate that streaming has solidified its position as the dominant mode of television consumption. According to Nielsen’s April edition of its monthly Gauge report, streaming set an all-time high, accounting for 44.3% of total TV tune-in . This represented an increase of half a percentage point from the previous month and a notable 15% increase compared to April of the prior year. While streaming surges, traditional viewing formats continue to shrink, though they still hold significance. Over the same year-to-year span, broadcast viewership dropped by 7%, and cable viewership experienced an even steeper decline of 16%. Despite these year-over-year losses, broadcast and cable managed slight upticks month-over-month, often bolstered by major live events such as the men’s NCAA basketball tournament and the Masters golf tournament. Beyond the major platforms, newer players also marked milestones: YouTube and The Roku Channel both reached all-time highs in April, with YouTube capturing 12.4% of total TV watch-time. This dramatic audience shift benefits legacy shows that successfully span both linear airings and extensive streaming access. Image credit: Shondaland / Grey's Anatomy . Fair use. Grey's Anatomy: A Case Study in Acquired Content Power G rey’s Anatomy , created by Shonda Rhimes, is far more than a simple medical drama; it is a cultural phenomenon exploring themes of love, loss, and the complexities of the medical field. Premiering in March 2005, the show boasts an immense library of 22 seasons and 457 episodes. This sheer volume makes it an invaluable asset in the streaming wars, demonstrating the phenomenal Acquired Content Power  it wields across multiple platforms. In April, for instance, Grey’s Anatomy  drew a staggering 3.9 billion viewing minutes  across its streaming homes on Hulu and Netflix. This immense viewership rivals even the top-performing original streaming titles. Crucially, the show showcases how platform distribution matters: Netflix represented about 60% of the show’s total streaming viewership for the month of April. Seasonal Viewing Dynamics The show’s strength lies in its ability to simultaneously draw viewers into its vast back catalog while capitalizing on the demand for new episodes. The 21st season of the show, which aired on ABC and was available for next-day viewing exclusively on Hulu, provided a measurable streaming boost. Although Season 21 episodes represented only 3% of the total episode count available for streaming, they accounted for 10% of Grey’s Anatomy's  total streaming viewership that month. This statistic demonstrates the powerful synergy between linear programming, which creates immediate demand, and the streaming platforms that capture this next-day viewership. This dual-platform strategy is key to the overall Grey's Anatomy Streaming Success . Image credit: whatsondisneyplus . Fair use. The Battle for the Top Spot on Nielsen Streaming Data W hile Grey’s Anatomy  is a powerhouse, the overall Nielsen charts for the week of October 27th to November 2nd, 2025, highlight intense competition from new originals and major films. The most watched series of that week was the Netflix original Nobody Wants This , which claimed the #1 overall spot with 919K minutes watched. Ironically, this huge Netflix hit was produced by Disney's 20th Television. Other high-ranking content included The Witcher  and the movie A House Of Dynamite . However, Grey’s Anatomy  dominated the Acquired  category, reclaiming the top spot with 787K minutes viewed. It also secured the #4 position on the combined total chart. Disney continues to hold a significant presence in the acquired charts, not just with Grey’s Anatomy , but also with Bob’s Burgers  (683K minutes) and Bluey  (643K minutes), streamed across Hulu and Disney+. The enduring popularity of licensed content is further emphasized by the success of other non-original shows like NCIS  and Law & Order . The Enduring Appeal of Nostalgia and Back Catalogs The success of Acquired Content Power  is heavily dependent on content with vast libraries that offer binge-worthy options, such as Grey's Anatomy 's 457 episodes. The data confirms that audiences are drawn to familiarity and nostalgia, a factor that extends beyond long-running series to classic films. During the Halloween season measured by the Nielsen charts, Disney's classic spooky-themed movies—including Hocus Pocus , Coco , and The Nightmare Before Christmas —received a significant boost in viewership minutes, highlighting how holiday themes and established favorites drive streaming traffic. Similarly, the success of shows like Only Murders In The Building  is attributed not only to the release of new episodes but also to the continued viewing of its back catalog. Digital Engagement and Cultural Phenomenon T he impact of Grey's Anatomy  extends beyond pure viewing minutes, cementing its status as a measurable cultural phenomenon. The program consistently maintains high levels of online engagement, tracked through various metrics. As of December 2, 2025, the series was ranked #24 among the most popular TV shows online. It also held the #16 rank within the Drama genre. Its massive fan base translates into powerful social media metrics that drive visibility and conversation. The show boasts over 4.3 million followers on X (Twitter) , ranking #3 among tracked shows, and its dedicated Reddit community exceeds 877,000 members. While streaming data focuses on minutes watched, these social statistics confirm that the show’s longevity and compelling storylines, navigating the personal and professional lives of surgical interns and residents at Grey Sloan Memorial Hospital, maintain intense interest and continuous conversation in the digital sphere. This robust online presence is a crucial indicator of the show's continued relevance and potential for future Grey's Anatomy Streaming Success . 🔖 Key Takeaways The analysis of Nielsen Streaming Data  provides clear insights into the current media market dynamics: 🗝️ Streaming Dominance:  Streaming continues to expand its share of total TV viewing, reaching a record 44.3% in April 2025, while linear TV segments decline year-over-year. 🗝️ Acquired Content Power:  Established shows with massive episode counts, such as Grey's Anatomy  (457 episodes), are vital for streaming platforms, consistently delivering billions of minutes of viewing. 🗝️ Hybrid Success Model:  Shows that air new seasons on linear TV (like Grey's Anatomy  on ABC) and offer next-day streaming (Hulu) successfully harness both immediate demand and catalog viewership, driving overall high metrics. 🗝️ Cultural Longevity:   Grey's Anatomy  maintains its status as a cultural phenomenon, demonstrated by its consistently high rankings on the acquired streaming charts and its vast digital footprint, including 4.3 million X followers. 🌐 External sources “Grey’s Anatomy” Reclaims The Top Spot On The Nielsen Streaming Chart Grey's Anatomy Streaming Set Another Record In April, But ‘Grey’s Anatomy’ And ‘The White Lotus’ Prove Linear’s Reach, Nielsen Says Keywords: Grey's Anatomy Streaming Success Grey's Anatomy Streaming Success

Image credit: Deadline / Doc Martin . Fair use. T he popular British comedy-drama Doc Martin , which ran successfully on ITV from 2004 to 2022, is making its way across the Atlantic in a highly anticipated US remake. Set to premiere on FOX in January 2026, the new series is titled Best Medicine , a playful pun on the main character's surname. The original series was a massive hit, making star Martin Clunes  a household name in the UK over its ten-season, eighteen-year run. Now, American television favorite Josh Charles  (known for The Good Wife  and Unbreakable Kimmy Schmidt ) steps into the leading role of Dr. Martin Best, bringing the prickly, fish-out-of-water dynamic to the US East Coast. This project has garnered significant attention, not just because of the challenging task of remaking a beloved international hit, but because the original Doc Martin, Martin Clunes himself, is confirmed to make a guest appearance. Best Medicine  hopes to stick the landing as an unusual exception to the general skepticism often aimed at American remakes of British shows. The series is a medical comedy-drama that will explore the journey of a brilliant surgeon forced to confront his own deep-seated issues while navigating the quirky demands of small-town life. Content ⁉️ 1️⃣ The Premise and the Players 2️⃣ The Character Arc of Dr. Martin Best 3️⃣ The Return of the Original Doc: Martin Clunes 4️⃣ Release Details and Fan Reception 🔖 Key Takeaways Image credit: Soap Central / Doc Martin . Fair use. The Premise and the Players T he setup for Best Medicine  closely mirrors the original narrative, transplanting the action from Cornwall to an American locale. Josh Charles plays Dr. Martin Best, a brilliant surgeon who abruptly leaves his illustrious career in Boston . His new post is as the general practitioner in a quaint East Coast fishing village  where he spent summers during his childhood. The core conflict of the series immediately establishes itself: Dr. Martin Best possesses an undeniably brilliant medical mind, but his blunt and borderline rude bedside manner  instantly rubs the quirky and needy locals the wrong way. Even though Dr. Best is the only doctor the town has, he quickly alienates the community. Like the original Doc Martin, Dr. Best is initially disinterested in local events and gossip upon his arrival. However, the sources suggest that despite his hardened demeanor, he gradually comes to like his new home. The show features a strong ensemble cast alongside Charles. Abigail Spencer  ( Suits , Grey’s Anatomy ) plays the school teacher Louisa Gavin , who is flagged early on as the potential love interest for the difficult doctor. Annie Potts  ( Young Sheldon , Ghostbusters ) stars as Joan , Martin's aunt, serving as one of the few familiar faces he encounters upon his major relocation. Rounding out the main cast are Cree  (or Cree Cicchino) as Martin's assistant, Elaine Denton , and Josh Segarra  as sheriff Mark Mylow . Supporting roles also feature Didi Conn and Clea Lewis. The Character Arc of Dr. Martin Best W hile the external comedy stems from the clash between the sophisticated, grumpy doctor and the close-knit community, the sources emphasize that the real drama lies within Dr. Best himself. What the quirky locals don’t know is that Martin's terse demeanor and emotional distance are not merely personality flaws; they mask a debilitating new phobia and deep-seated psychological issues  that actively prevent him from experiencing true intimacy with anyone. This crucial internal conflict sets up the series-long character arc  for Dr. Best: he must learn to open up, become a fully integrated member of the community, and ultimately, become a nicer person. The trailer even indicates that the pilot episode will lean heavily into the running "Doc Martin" joke—a nickname the character Dr. Martin Best "hates so much". This development ensures that the character growth—or lack thereof, initially—will be central to the show’s longevity. Why the New Name? One intriguing detail noted by commentators is why FOX chose to call the show Best Medicine  rather than simply retaining the successful title of Doc Martin . The most plausible explanation offered is that the US producers likely wished to avoid confusing American audiences  with the British original, which was a massive hit that ran for nearly two decades. Thus, the title Best Medicine  was chosen, utilizing the lead character's surname, Dr. Martin Best, to create a memorable, if slightly obvious, pun. Image credit: TV Insider / Doc Martin . Fair use. The Return of the Original Doc: Martin Clunes T he announcement that original Doc Martin  star Martin Clunes  would participate in the remake caused significant excitement among fans. Clunes will guest-star, playing the father of the American lead, Dr. Robert Best . Dr. Robert Best is confirmed to be a recurring role in the series. The character of Robert Best is positioned as an accomplished gastroenterologist and a figure whose presence will undoubtedly complicate Martin’s life. According to a press release, Robert is described as a "headstrong man who makes his stoic son seem warm by comparison,"  indicating he holds a sardonic view of the world  that rivals even his son’s characteristic grumpiness. Martin Clunes’ portrayal of Robert is expected to be exciting for fans who appreciated his wittiest putdowns in the original series. More than just a guest role, the sources hint at a complex dynamic between father and son. Martin Clunes's character is expected to make his son miserable, suggesting a path toward some kind of eventual reconciliation. Crucially, the sources confirm that Robert Best is "hiding a few secrets of his own that could turn Martin's new life upside down,"  forcing the younger Dr. Best to confront his past. This sets the stage for high-stakes familial drama layered on top of the established small-town comedy. Release Details and Fan Reception B est Medicine  is set to premiere on FOX in January 2026 . In the US, episodes will stream afterward on Hulu. The UK rollout plan remains to be confirmed. The release of the first-look trailer generated immediate buzz, with many fans of the original series expressing their enthusiasm online. One fan noted, "Can’t wait to see the real Doc Martin aka Martin Clunes on the show!". Another fan expressed excitement for the US cast, stating, "We love the UK version and cannot wait to see this US remake. Looks really fun! Josh Charles and Annie Potts - really excited for this!". Despite the excitement, the sources acknowledge that viewers, particularly British fans, maintain a "healthy degree of skepticism"  whenever beloved UK shows are remade for an American audience. However, the strength of the cast and the involvement of Clunes has raised hopes that Best Medicine  might be the rare exception that manages to successfully capture the original show's charm and spirit. The challenge for Best Medicine  is similar to the complex process of transferring a cherished family recipe to a new kitchen: the core ingredients (the abrasive doctor, the quirky town, the romance) are all present, but the execution must maintain the flavor and heart of the original while adding a unique, regional twist. With Josh Charles leading the cast and Martin Clunes providing a nod to the original heritage, the Doc Martin Remake  is positioned as a highly anticipated entry in the 2026 television lineup. 🔖 Key Takeaways 🗝️ Best Medicine   is the US remake  of the long-running ITV hit Doc Martin , set to premiere on FOX in January 2026 . 🗝️ Josh Charles  stars as Dr. Martin Best, a brilliant but grumpy Boston surgeon who relocates to a quaint East Coast fishing village. 🗝️ Dr. Best’s abrasive manner stems from a debilitating new phobia and psychological issues  that form the core of his journey toward personal growth. 🗝️ Original star Martin Clunes will guest-star  as Dr. Robert Best, Martin’s equally sardonic father, who holds secrets that could disrupt Martin’s new life. 🗝️ The ensemble cast includes Abigail Spencer  (as love interest Louisa Gavin) and Annie Potts  (as Aunt Joan). 🗝️ While some skepticism exists regarding American remakes, fan reaction to the casting and Clunes' involvement has been largely enthusiastic. The US streaming partner for the series will be Hulu. 🌐 External sources Doc Martin's US remake releases first look trailer with flurry of American TV favourites Doc Martin remake with Martin Clunes shares first look trailer and fans "can't wait" Best Medicine Teaser Previews FOX's Remake of UK's "Doc Martin" Keywords: Doc Martin Remake Doc Martin Remake

T he field of mental health genetics has witnessed a major development with the identification of the GRIN2A gene  as a singular cause of schizophrenia and other psychiatric disorders . This breakthrough research, published in Molecular Psychiatry , directly challenges the long-standing belief that conditions like schizophrenia result solely from the interplay of multiple genetic and environmental factors (polygenic causes). Professor Johannes Lemke, Director of the Institute of Human Genetics at the University of Leipzig Medical Centre, led the German study. Professor Lemke stated that the current findings indicate that GRIN2A  is the "first known gene that, on its own, can cause a mental illness,"  distinguishing it from the polygenic models previously assumed. Researchers analyzed data from 121 individuals carrying genetic alterations in GRIN2A . A striking finding was that these specific gene changes were associated not only with schizophrenia but also with other mental illnesses that developed in childhood or adolescence , preceding the typical adult onset of schizophrenia. The team also noted that some participants displayed only psychiatric symptoms, despite GRIN2A  changes usually being linked to conditions like epilepsy or intellectual disability. The GRIN2A  gene is crucial for regulating the electrical excitability of nerve cells. Variants found in the gene led to reduced activity of the NMDA receptor , a key molecule involved in brain signaling, learning, memory, and cognition. This disruption provides a concrete genetic target for intervention. Collaborating with Dr. Steffen Syrbe, the clinicians demonstrated therapeutic potential: in an initial treatment series, patients experienced marked improvements in psychiatric symptoms after receiving L-serine . L-serine is a dietary supplement that functions by activating the NMDA receptor, suggesting that treatments targeting this underlying biological cause are possible. This discovery holds substantial implications for public health, potentially allowing for earlier screening and intervention  before the full manifestation of symptoms, thereby improving prognosis. Moreover, associating mental illness with identifiable genetic changes can help reduce stigma . Experts emphasize, however, that while a major stride, schizophrenia remains complex. The study involved a relatively small sample size, and many cases of schizophrenia continue to involve polygenic and non-genetic factors. Genetic testing is not yet recommended for routine clinical use  pending further validation and ethical review. 🔖 Sources Scientists discover first gene proven to directly cause mental illness " Breakthrough Study Identifies GRIN2A as a Single Gene Cause of Schizophrenia and Mental Illness" Scientists Identify First-Ever Single Gene That Can Directly Cause Mental Illness Keywords: First Single Gene Cause Mental Illness First Single Gene Cause Mental Illness

A critical shift in U.S. vaccination policy is brewing as a group of advisers to the Centers for Disease Control and Prevention (CDC) prepares to vote on whether to scrap or delay the long-standing recommendation that every baby receive a hepatitis B vaccination within 24 hours of birth. This move, pushed by skeptics who question the universal benefit of the shot, could be the most consequential policy change since Health Secretary Robert F. Kennedy Jr. began remaking vaccine policy. The hepatitis B vaccine, universally recommended for newborns since the early 1990s, is credited with dramatically reducing acute hepatitis B infections in children by 99%. The virus, which can be transmitted from mother to baby during childbirth, is incurable and can lead to liver disease and early death. According to one review, the birth dose policy has prevented more than 6 million infections and nearly 1 million hospitalizations. Liver cancer in children has disappeared in some previously high-risk communities since 1995 due to widespread vaccination efforts. The Advisory Committee on Immunization Practices (ACIP), which is scheduled to meet on Thursday and Friday, recently underwent significant leadership changes, with members skeptical of vaccines being appointed, including new ACIP chair, pediatric cardiologist Dr. Kirk Milhoan. Milhoan argued that the decision to give newborns the vaccine should be based on a clinician’s assessment of the baby’s individual risk, such as whether the pregnant mother tested positive for the infection. He also cited the risk of neonatal fever associated with the "day one" shot, which can trigger additional medical interventions. However, mainstream medical experts and data strongly counter these concerns. Dr. Sean O’Leary, a spokesman for the American Academy of Pediatrics, stated that he has never seen a serious reaction or a fever associated with the hepatitis B vaccine after thousands of administered doses. Furthermore, a review of over 400 studies found no evidence  that the birth dose causes any short- or long-term health problems. Doctors warn that delaying the shot could revive deadly cases. Hepatitis B is highly infectious, capable of spreading through sexual contact, sharing drug paraphernalia, and even through microscopic amounts of blood or bodily fluids left on shared items like toothbrushes, razors, or toys. While the CDC recommends screening all pregnant people for the virus, up to 16% are not tested and may fall through the cracks. Experts emphasize that if the mother happens to be positive, waiting a month to vaccinate establishes the infection in the baby’s liver, making prevention too late. Without vaccination, 90% of babies exposed to the virus during birth develop chronic hepatitis. The ACIP’s recommendations hold significant weight, as they influence insurance coverage for vaccines. Furthermore, vaccine makers have expressed concerns that even small changes to the schedule could disrupt the U.S. supply of the hepatitis B vaccine, or combination vaccines, for a year or longer. Vaccine proponent Dr. William Schaffner advises expectant parents to talk to their doctors about the strong safety profile of the three-dose vaccine series, noting that the only common adverse events reported are minor fussiness and crying. Experts like Schaffner and O'Leary stress that the universal birth dose is the best way to prevent the establishment of this incurable infection. 🔖 Sources CDC advisers could reverse newborn hepatitis B vaccine recommendations Doctors warn delaying hepatitis B shot for newborns could revive a deadly threat US vaccine committee's hepatitis B changes would be most consequential yet Keywords: Hepatitis B Birth Dose Recommendation Hepatitis B Birth Dose Recommendation

A German man, often referred to as Berlin 2 (B2) and reported to be 60 years old, has become the seventh known patient worldwide to achieve long-term remission from HIV. This extraordinary development occurred six years after he received a stem cell transplant to treat an aggressive form of acute myeloid leukemia (cancer). The patient was first diagnosed with HIV in 2009 and developed leukemia in 2015. Following chemotherapy to wipe out most of his immune system, he received a full stem cell transplant later that year. In 2018, against medical advice, he stopped taking antiretroviral therapy (ART). Since that time, virus levels in his body have remained undetectable and may be nonexistent. While ART is the cornerstone of treatment for HIV, making life manageable and suppressing the virus’s progression, it does not eliminate the virus. HIV is a tenacious virus that attacks immune cells and can remain dormant within long-lived immune cells, forming latent reservoirs that are essentially invisible to the immune system and untouched by ART. If ART is stopped, the virus can re-emerge. Full stem cell transplants, however, have a proven record in depleting these reservoirs. In five of the seven documented cases of long-term HIV remission (including the original Berlin patient, London, Duesseldorf, New York, and City of Hope patients), the stem cell donors possessed two copies  (homozygous) of a rare mutation called CCR5 Δ32. This mutation breaks the CCR5 "keyhole" that HIV exploits to attach to and enter host cells, essentially preventing the virus from unlocking the door and depriving it of new places to hide. What makes B2's case a significant breakthrough is the characteristic of his donor. Unlike the majority of successful previous cases, B2 received donor stem cells containing only one copy  (heterozygous) of the CCR5 Δ32 mutation. B2 himself already had one inherited copy of the mutation. Previously, experts had assumed that homozygous donor cells (two copies) were essential for curing HIV. The success achieved with B2—who remains HIV-free three years after stopping ART—suggests that double copies of CCR5 Δ32 are not a requirement  for durable HIV remission after stem cell treatment. This shifts the focus away from relying on rare "unicorn donors" who carry two copies of the mutation. Researchers led by immunologist Christian Gaebler believe this result offers a tantalizing new path toward understanding other potential ways of curing HIV. The key may be mechanisms like the graft-versus-reservoir response —where the new donor cells recognize and wipe out remaining HIV hideouts—and sustained reduction of persistent reservoirs. This case, along with the sixth patient from Geneva whose donor completely lacked the CCR5 Δ32 allele, supports the idea that significant reductions of persistent reservoirs can lead to HIV cure independent of homozygous CCR5 Δ32-mediated viral resistance. These mechanisms may be achievable through pharmaceutical treatments and gene editing, and research is already underway to that effect. The success of the stem cell procedure underscores the critical importance of modulating and potentially eliminating the HIV reservoir in strategies aimed at long-term remission and cure. The findings for the Berlin patient (B2) were published in the journal Nature . 🔖 Sources 7th HIV Remission Raises Hope of Long-Lasting Treatment For More People Another HIV Patient Goes Into Remission After Cancer Treatment Keywords: Long-Term HIV Remission Breakthrough   Long-Term HIV Remission Breakthrough

Image Credit: People.com . Fair Use. S eason 21 of Grey’s Anatomy  pushed the boundaries of surgical innovation while revisiting classic, high-stakes trauma. From awake kidney transplants to groundbreaking osseointegration for amputees, the medicine was as cutting-edge as ever. The season also tackled deeply personal medical crises for the staff, including a pregnancy complication for Jo Wilson and Catherine Fox's battle with cancer complications. Below is a comprehensive, episode-by-episode review of the medical cases, diagnoses, and treatments presented in Season 21. Content ⁉️ 1️⃣ Episode 1 2️⃣ Episode 2 3️⃣ Episode 3 4️⃣ Episode 4 5️⃣ Episode 5 6️⃣ Episode 6 7️⃣ Episode 7 8️⃣ Episode 8 9️⃣ Episode 9 🔟 Episode 10 1️⃣1️⃣ Episode 11 1️⃣2️⃣ Episode 12 1️⃣3️⃣ Episode 13 1️⃣4️⃣ Episode 14 1️⃣5️⃣ Episode 15 1️⃣6️⃣ Episode 16 1️⃣7️⃣ Episode 17 1️⃣8️⃣ Episode 18 🔖 Key Takeaways Episode 1 Severe Chest Trauma from Vehicular Crash C harlie Scott. A driver struck by falling bungee jumpers suffered catastrophic blunt trauma, including a displaced clavicle fracture and bilateral hemophoresis. Progression:  Hypotension and tachycardia indicated massive internal bleeding. Emergency surgery revealed venous bleeding from the subclavian vein , injured by the clavicle fracture. Treatment:  A subclavian incision allowed for vascular repair. However, his severed index finger could not be reattached due to ischemia time. Expanding Neck Hematoma and Airway Compromise Wanda Gallagher. A protestor on Warfarin for DVT suffered blunt neck trauma. She disappeared into the hospital ceiling, where she developed acute respiratory distress. Diagnosis:  An expanding neck hematoma compromised her airway. Treatment:  An emergency decompression was performed in the ceiling to secure the airway, followed by formal neck exploration and ligation in the OR. Subacute Budd-Chiari Syndrome Catherine Fox. Catherine Fox, battling cancer, collapsed due to Subacute Budd-Chiari Syndrome —a clot in the hepatic vein and IVC caused by her hypercoagulable state. Treatment:  She refused invasive procedures like TIPS, opting for heparin anticoagulation to preserve her quality of life. Other Medical Conditions Discussed Bilateral Hemophoresis:  Blood in both sides of the chest. Alzheimer's Research:  Ongoing studies mentioned. Episode 2 Diffuse Intrinsic Pontine Glioma (DIPG) and Li-Fraumeni Syndrome C al Huang. A teen with Li-Fraumeni Syndrome  (genetic cancer predisposition) presented with back pain. Imaging found a thoracic schwannoma compressing the spinal cord. Progression:  After successful tumor removal, he suffered a medical event. Scans revealed a new, fatal diagnosis: DIPG , an aggressive brainstem tumor with a terminal prognosis. Aorto-Esophageal Fistula Nora Young. A patient with a prior esophageal perforation from a Nissen fundoplication suffered massive hematemesis (vomiting blood). Diagnosis:  An aorto-esophageal fistula , a life-threatening connection between the aorta and esophagus. Treatment:  A Minnesota tube halted bleeding temporarily. Definitive repair involved a TEVAR  (thoracic endovascular aortic repair) stent graft. Hepatic Lesions (Benign vs. Malignant) Catherine Fox. Follow-up scans showed liver lesions. While metastasis was feared, Dr. Bailey pushed for a biopsy to rule out benign causes like hemangiomas or fatty changes from Budd-Chiari syndrome. Other Medical Conditions Discussed Adrenocortical Carcinoma:  A previous cancer in the Li-Fraumeni patient. Thoracic Schwannoma:  A benign tumor compressing the cord. Episode 3 Hemangioblastoma in Pregnancy R hiannon Fletcher. A pregnant surrogate developed a thoracic hemangioblastoma . Pregnancy hormones accelerated its growth, threatening paralysis. Treatment:  Despite high risks, neurosurgery removed the tumor to save the patient's mobility and the pregnancy. Emergency TIPS Procedure Catherine Fox. During a liver biopsy, Catherine suffered esophageal hemorrhage. Treatment:  An emergency TIPS procedure  (shunt) was performed to stop the bleeding and prevent liver failure. Awake Kidney Transplant Tom Costello. A scrub nurse underwent a kidney transplant  under spinal anesthesia without general anesthesia. This "awake" surgery aimed to speed recovery. Other Medical Conditions Discussed Hepatitis C:  Research mentioned regarding viral "masking." Congestive Heart Failure:  A patient with low ejection fraction. Episode 4 Rectal Cancer and Ovarian Transposition C hloe Yasuda. Intern Mika Yasuda’s sister was diagnosed with Stage 3B rectal cancer . To preserve fertility before radiation, she underwent Ovarian Transposition , moving the ovaries out of the radiation field. Necrotizing Fasciitis (Post-BBL) Judith Dunn. A patient with diabetes and a recent Brazilian Butt Lift (BBL)  suffered a thigh laceration that rapidly progressed to Necrotizing Fasciitis . Treatment:  Emergency debridement of the glute and thigh was required to stop the spread of infection. Multi-Drug Resistant Pneumonia (ECMO) Darren Riley. A patient with pulmonary fibrosis developed severe pneumonia. He failed conventional ventilation and was placed on VV ECMO  to oxygenate his blood. Other Medical Conditions Discussed Hip Joint Effusion:  A differential for hip pain. Sepsis:  A complication of the necrotizing infection. Episode 5 Necrotizing Pneumonia (Pneumonectomy) D arren Riley. The pneumonia patient (Ep 4) developed lung necrosis ("liquified lung"). Treatment:  A total pneumonectomy  (removal of the lung) was performed. He remained on ECMO as a bridge to transplant. Avascular Necrosis (Sickle Cell Disease) Zayne Johnson. A patient with Sickle Cell Disease presented with hip pain due to Avascular Necrosis  (bone death). He underwent a total hip replacement. Organophosphate Poisoning Ofelia Lopez. A pediatric trauma patient exposed to farm pesticides developed organophosphate poisoning  (bradycardia, pinpoint pupils). She was treated with atropine. Surgical Innovation:  A temporary vascular shunt using IV tubing was placed in-flight to save her leg from ischemia. Cardiac Tamponade (Post-Op) Aurelio Wheeler. A post-cardiac surgery patient developed cardiac tamponade  (fluid compressing the heart). An emergency bedside procedure relieved the pressure. Other Medical Conditions Discussed Triplets:  High-risk pregnancy mentioned. Nonfunctional Spleen:  A consequence of Sickle Cell Disease. Episode 6 Metastatic Adenocarcinoma M r. Jiménez. An incarcerated patient evaluated for TB was found to have widespread metastatic adenocarcinoma . The cancer was inoperable, and he transitioned to palliative care. Osseointegration for Amputation Misty Valentine. A teen amputee suffered socket pain. Dr. Lincoln performed osseointegration , implanting a titanium rod directly into the femur for prosthetic attachment. Targeted Muscle Reinnervation (TMR)  was also performed to reduce phantom pain. Upper GI Bleed (Stress Ulcer) Dorian. A long-term ICU patient developed a stress ulcer causing a massive GI bleed. It was treated endoscopically with epinephrine and clips. Other Medical Conditions Discussed Phantom Pain:  Neurological pain in a missing limb. Necrotizing Enterocolitis:  Mentioned as a cause of death in a NICU patient. Episode 7 HELLP Syndrome and Eclampsia L auren Ferguson. A pregnant patient progressed to eclampsia and HELLP Syndrome . During a crash C-section, she developed a ruptured liver hematoma and DIC , requiring a hysterectomy and massive transfusion. Arnold-Chiari Malformation Gillian Mendelson. A trauma patient’s headache was relieved by yelling. This led to the diagnosis of Arnold-Chiari Malformation  (brain tissue extending into the spinal canal). Enterocutaneous Fistula Dorian Cardenas. Dorian developed an enterocutaneous fistula  (leakage from bowel to skin), requiring NPO status and eventual surgical repair. Other Medical Conditions Discussed Uterine Atony:  A cause of postpartum hemorrhage. Episode 8 Frozen Abdomen and STEP Procedure D orian Cardenas. During fistula repair, Dorian was found to have a "frozen abdomen" (massive scar tissue). Resection would cause Short Bowel Syndrome . Treatment:  Surgeons performed a Serial Transverse Enteroplasty (STEP)  to lengthen the bowel and improve absorption. Neurofibroma Caroline Early. A teen's knee lump was identified as a neurofibroma  on the nerve sheath, requiring careful neurosurgical excision. Other Medical Conditions Discussed Cystic Fibrosis:  Mentioned in a teen patient. Tension Pneumothorax:  A trauma complication. Episode 9 Domino Heart Transplant M ason Peterson & Brady Hauser. A rare "domino transplant" was performed. Patient 1 (Mason):  Had pulmonary hypertension. He received a heart-lung block. Patient 2 (Brady):  Received Mason's native heart, which was healthy but maladapted to Mason's lung pressures. Treatment:  Brady required complex SVC reconstruction to accept the new heart. Other Medical Conditions Discussed Chronic Rejection:  The cause of Brady's heart failure. Episode 10 Ruptured Abdominal Aortic Aneurysm (AAA) G arrett. A patient’s elective AAA repair was cancelled due to a wildfire influx. The aneurysm ruptured, and despite emergency surgery, the repair failed, leading to fatal hemorrhage. SMA Avulsion (Crush Injury) Theo Ruiz. A firefighter suffered a crush injury that avulsed the Superior Mesenteric Artery (SMA) . Dr. Altman performed a vascular reconstruction with a saphenous vein graft to save the bowel and life. Other Medical Conditions Discussed Biliary Atresia:  A pediatric surgery case. Smoke Inhalation:  Treated in wildfire victims. Episode 11 Split Liver Transplant T asha Lawson & Lisa Saito. Two patients needed a liver: Tasha (PSC/Alzheimer's) and Lisa (Acetaminophen toxicity). Solution:  A split liver transplant  gave Tasha the larger portion and Lisa the smaller portion as a bridge to recovery. Temporal Lobe Epilepsy Molly. A patient with Temporal Lobe Epilepsy  underwent Deep Brain Stimulation (DBS). Experimental memory retrieval surgery was performed simultaneously. Other Medical Conditions Discussed Acetaminophen Hepatotoxicity:  Liver failure from overdose. Episode 12 Carcinoid Syndrome M elissa Walker. A patient with flushing and diarrhea post-cholecystectomy was diagnosed with Carcinoid Syndrome  from a neuroendocrine tumor on the appendix. She underwent an appendectomy. Pectus Excavatum (Nuss Procedure) Carlos Navarro. A teen underwent a modified Nuss procedure  to correct a sunken chest. Complication:  A needle puncture to the heart required a pericardial window. Other Medical Conditions Discussed Alzheimer's Research:  Research into the gut microbiome connection continued. Episode 13 Achalasia with Megaesophagus in Pregnancy L iz. A pregnant patient with severe indigestion was found to have Achalasia  (esophagus fails to relax) causing food impaction. Treatment:  Esophageal disimpaction and Botox injection into the sphincter. Other Medical Conditions Discussed PTLD:  Post-transplant lymphoproliferative disorder. Episode 14 Pancreatic Adenocarcinoma (Vascular Reconstruction) G abby Mims. A patient with a pancreatic tumor encasing the SMA underwent resection. Innovation:  The SMA was reconstructed using a saphenous vein graft to allow tumor removal. Penetrating Aortic Injury Brendon Browning. A patient impaled by an ice pick suffered a fatal aortic injury when the object moved. Tibia Malunion Jack Moss. A patient with a malunited fracture and vascular kink underwent osteotomy and bypass to save the leg. Other Medical Conditions Discussed Mesothelioma:  Treated with HIPEC. Episode 15 Transverse Vaginal Septum N avy Sutherland. A teen with abdominal pain and amenorrhea was diagnosed with a Transverse Vaginal Septum  trapping menstrual blood (hematometra). Treatment:  A laparoscopic incision drained the blood, avoiding external drains. Carotid Artery Laceration Beau Caraway. A window washer suffered a carotid artery laceration . During repair, a clot formed, requiring a thrombectomy. Other Medical Conditions Discussed Mesenteric Tear:  Repaired via laparoscopy. Episode 16 Deep Infiltrative Endometriosis (DIE) M ariana. A patient with severe pain had Deep Infiltrative Endometriosis  invading the pubic bone. Treatment:  Multidisciplinary excision involving shaving the bone and removing pelvic lesions. Brain Stem Cavernous Angioma Dylan Gatlin. A child had a cavernous angioma  in the brain stem. Innovation:  Using DTI mapping ("trail map"), Dr. Shepherd resected the lesion. However, the patient woke up with Locked-In Syndrome. Other Medical Conditions Discussed Lung Herniation:  A rare chest wall injury. Episode 17 Locked-In Syndrome D ylan Gatlin. Post-op from the angioma resection, Dylan developed Locked-In Syndrome  due to a hematoma. Conservative management failed, necessitating re-operation. Infected Aortic Graft Nora Young. Nora (Ep 2) returned with an infected graft and aortoenteric fistula . An ax-fem bypass failed due to hypercoagulability, leaving no surgical options. Toxic Megacolon (C. diff) Deb. Antibiotic use led to C. diff  colitis and Toxic Megacolon . The colon perforated, requiring an emergency colectomy. Other Medical Conditions Discussed Hypercoagulopathy:  Complicating vascular repairs. Episode 18 Experimental Aortic Reconstruction N ora Young. With no other options, surgeons performed a "Hail Mary" procedure to build a new aorta from a synthetic graft, diverting blood flow away from the infection. Post-Op Coagulopathy Dylan Gatlin. During re-operation for the brain stem hematoma, Dylan developed coagulopathy . FFP was used to control bleeding and successfully close. Shattered Liver Carter Samuels. A trauma patient re-bled in the ICU. Surgeons performed a bedside exploratory laparotomy to control mesenteric bleeding. Other Medical Conditions Discussed Acidosis:  A sign of physiological decompensation. 🔖 Key Takeaways 🗝️ Surgical Firsts:  Season 21 showcased advanced procedures like the Awake Kidney Transplant  and Osseointegration  for amputees, highlighting trends toward faster recovery and better quality of life. 🗝️ Complex Oncology:  The show explored the surgical management of complex cancers, from Ovarian Transposition  to preserve fertility to vascular reconstruction  for pancreatic tumors. 🗝️ Trauma Innovation:  The use of REBOA  and bedside laparotomies  in the ICU demonstrated the evolving nature of critical care trauma management. 🗝️ Rare Diagnoses:  Conditions like Achalasia , Moebius Syndrome , and Situs Inversus  provided unique diagnostic challenges. 🗝️ Neuro-Navigation:  The use of DTI mapping  in brain stem surgery illustrated the intersection of technology and neurosurgery. Keywords: Medical Diagnoses Grey's Anatomy Season 21 Medical Diagnoses Grey's Anatomy Season 21